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T-Stenting and Small Protrusion Technique
for Coronary Bifurcation LesionsToru Naganuma, MD,*yz Azeem Latib, MD,*y Sandeep Basavarajaiah, MD,*y
Alaide Chieffo, MD,* Filippo Figini, MD,* Mauro Carlino, MD,* Matteo Montorfano, MD,*
Cosmo Godino, MD,* Santo Ferrarello, MD,* Tasuku Hasegawa, MD,*y
Masanori Kawaguchi, MD,*y Sunao Nakamura, MD,z Antonio Colombo, MD*y
Milan, Italy; and Chiba, JapanObjectives This study sought to report long-term clinical outcomes in patients treated with the
provisional T-stenting and small protrusion (TAP) technique.
Background Several strategies have been proposed for treating bifurcation lesions, each with its own
merits and technical challenges. The TAP technique is a relatively new strategy that is technically less
challenging, ensures complete coverage of the side-branch ostium, and minimizes stent overlap.
Although there is reasonable amount of data for other bifurcation strategies, the long-term clinical
outcomes for TAP technique are limited.
Methods We retrospectively evaluated all patients who underwent TAP technique with drug-eluting
stents between July 2005 and January 2012. The measured endpoints at follow-up were major adverse
cardiac events deﬁned as composite of cardiac death, myocardial infarction, and target vessel
revascularization.
Results A total of 95 patients (81.1% men) with a mean age of 64.8 years underwent TAP stenting.
Procedural success was achieved in 100% of cases. True bifurcation was observed in 75 (78.9%) patients.
First-generation drug-eluting stents were used in 55.8% of patients. The outcome rates at 3-year follow-
up of major adverse cardiac events, cardiac death/follow-up myocardial infarction, target vessel
revascularization, and target lesion revascularization were 12.9%, 3.1%, 9.7%, and 5.1%, respectively.
There were no cases of follow-up myocardial infarction or stent thrombosis (deﬁnite and probable).
Conclusions These results demonstrate that TAP technique is associated with acceptable clinical
outcomes with no episodes of deﬁnite and probable stent thrombosis. Further studies should compare
TAP technique with other 2-stent strategies. (J Am Coll Cardiol Intv 2013;6:554–61) ª 2013 by the
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Abbreviations
and Acronyms
DES = drug-eluting stent(s)
FKBI = ﬁnal kissing balloon
inﬂation
IQR = interquartile range
MACE = major adverse
cardiac events
MB = main branch
MI = myocardial infarction
PCI = percutaneous coronary
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555Although there are no formal guidelines on the strategies for
percutaneous coronary intervention (PCI) involving major
anatomic bifurcations, the current consensus is to consider
provisional stenting as the default strategy for most bifurca-
tions (1,2). The 2-stent approach is generally reserved for
complex bifurcations. However, up to 30% of cases treated
with provisional stenting require crossover to 2-stenting due
to ﬂow compromise in the side branch (SB) resulting from
plaque and/or carina shift or dissection at the ostium of the
SB (3–5). The bailout stenting options in such situations are
reverse culotte, reverse crush, or reverse T-stenting. Reverse
culotte and reverse crush stenting are technically challenging
and may not be successful in all cases. In addition, they
prolong procedural time, radiation, and contrast load (5,6).
Reverse T-stenting can only be optimally performed in
bifurcations with 90 angulation. T-stenting and small pro-
trusion (TAP) is a relatively new technique, which is tech-
nically less challenging and ensures complete coverage of the
SB ostium and minimizes stent overlap (7). Unlike other
strategies, the TAP technique does not involve recrossing of
the stent to perform ﬁnal kissing balloon inﬂation (FKBI)
following deployment of the SB stent. Although there are
reports on the outcomes following traditional crush and culotte
techniques, there is scarcity of data on the long-term clinical
outcomes followingTAP stenting.We performed this study to
evaluate the long-term clinical outcomes of TAP technique
using drug-eluting stents (DES) in our cohort of patients.intervention
SB = side branch
ST = stent thrombosis
TAP = T-stenting and small
protrusion
TIMI = Thrombolysis In
Myocardial Infarction
TLR = target lesion
revascularization
TVR = target vessel
revascularizationMethods
We retrospectively evaluated all patients who underwent
the TAP technique with DES for bifurcation lesions
between July 2005 and January 2012 at 3 high-volume
centers: 1) San Raffaele Scientiﬁc Institute, Milan, Italy; 2)
New-Tokyo Hospital, Chiba, Japan; 3) EMO-GVMCentro
Cuore Columbus, Milan, Italy. The initial intended strategy
for the bifurcation lesions was the provisional stenting
technique, with crossover to TAP stenting when at least 1 of
the following conditions was met: residual stenosis 50%;
type B or higher grade of dissection; or TIMI (Thrombolysis
In Myocardial Infarction) ﬂow grade <3.
Procedure. The following steps were employed for TAP
stenting:
 Wiring of the main branch (MB) and SB;
 Pre-dilation of MB and/or SB at the operator’s
discretion;
 Stenting of the MB by jailing the SB (Fig. 1A);
 Angiographic evaluation of the result; and
 Decision whether to perform kissing balloon inﬂation.
If yes, rewiring the SB through the stent, followed by
balloon dilation to open the stent struts and MB
balloon dilation (Fig. 1B).At this stage, if the result was acceptable, the procedure was
concluded. However, if there was compromise to the SB
ﬂow, a second stent was deployed as follows.
 A stent was positioned in the SB with the aim to
protrude as minimally as possible, ensuring complete
coverage of the ostium of SB.
 The SB stent was deployed, while the uninﬂated
balloon remained parked in the MB at the bifurcation
(Fig. 1C).
 The SB stent balloon was pulled backward slightly,
ensuring that it was still within the MB stent. Subse-
quently, simultaneous FKBI was performed using the
SB balloon and the previously positioned MB balloon
at high pressure (Fig. 1D). The SB balloon was
deﬂated last.
 The SB stent completely
covered the ostium
(Fig. 1E).
Clinical data was collected during
hospital visit or by telephone
consultation. The antiplatelet
regimens were low-dose aspirin,
which was recommended indeﬁ-
nitely, and a thienopyridine (200
to 250 mg of ticlopidine bid or
75 mg of clopidogrel daily) for
aminimumof 6months after PCI.
Quantitative coronary angio-
graphic measurements. Matched
orthogonal views were used for
quantitative analysis before and
after treatment. Angiography
was performed after intra-
coronary injection of nitroglyc-
erine (100 to 200 mg).
Angiograms were analyzed by
means of the Clinical Measure-
ments Solutions system (QCA-CMS, version 5.1, Medis
Medical Imaging Systems, Leiden, the Netherlands).
Quantitative coronary analysis measurements were per-
formed at baseline and after stent implantation on both MB
and SB. Minimal lumen diameter, diameter stenosis, acute
gain, and reference vessel diameters were measured.
Endpoint deﬁnitions. The measured endpoints were major
adverse cardiac events (MACE) during the follow-up period.
MACE was deﬁned as composite of cardiac death, myocar-
dial infarction (MI), and target vessel revascularization
(TVR). Death was considered cardiac in origin unless obvious
noncardiac causes could be identiﬁed. MI was deﬁned as the
presence of pathological and new Q waves on an electrocar-
diogram, or an increase in creatine kinase-myocardial band
level to >3 the upper limit of the normal range. TVR was
Figure 1. Steps for TAP Technique
(A) Stenting of the main branch (MB) by jailing the side branch (SB). (B) If performing kissing balloon inﬂation, rewiring the SB through the stent, followed by balloon
dilation to open the stent struts and MB balloon dilation. (C) Positioning SB stent with minimal protrusion into the MB. Positioning an uninﬂated balloon in the MB at
the bifurcation, with subsequent deployment of the SB stent. (D) Retracting the SB balloon slightly and performing the ﬁnal kissing balloon inﬂation. (E) The ﬁnal
picture demonstrating complete stent coverage of the SB ostium with a neo-carina. TAP ¼ T-stenting and small protrusion.
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556deﬁned as repeat PCI or coronary artery bypass graft for
the target vessel. Target lesion revascularization (TLR) was
deﬁned as repeat PCI or coronary artery bypass graft for the
lesion in the previously stented segment or in the adjacent
5 mm. The occurrence of stent thrombosis (ST) was deﬁned
on the basis of the Academic Research Consortium deﬁni-
tions (8). Bifurcation lesions were classiﬁed according to
Medina class by 2 independent physicians (9). The Euro-
SCORE (European System for Cardiac Operative Risk
Evaluation) (10) and the SYNTAX (Synergy Between
Percutaneous Coronary Intervention With Taxus and
Cardiac Surgery) score were calculated (11). Procedural
success was deﬁned as completion of the procedure with no
in-lab complications, ﬁnal TIMI ﬂow grade 3 with residual
stenosis <20% in MB and SB.
Statistical analysis. The values were presented as mean 
SD or median (interquartile range [IQR]) for continuous
variables or as counts and percentages for categorical vari-
ables. Time-to-event curve was generated using Kaplan-
Meier methods. Analyses were carried out using SPSS for
Windows (version 19.0, SPSS Inc., Chicago, Illinois).
Results
Patient demographics. During the study period, 2,396
bifurcation lesions in 2,360 patients were treated by PCI
using DES. Of these, 95 lesions (4%) in 95 patients witha mean age of 64.8  9.5 years (range 40 to 85 years)
underwent TAP stenting: 46 at San Raffaele Scientiﬁc
Institute, Milan, Italy; 32 at New-Tokyo Hospital, Chiba,
Japan; 17 at EMO-GVM Centro Cuore Columbus, Milan,
Italy. The reasons for TAP stenting were: type B or higher
grade of dissection in the SB in 31 (32.6%) patients; residual
stenosis deﬁned as 50% at the SB ostium with TIMI ﬂow
grade 3 in 58 (61.1%) patients; residual stenosis deﬁned as
50% at the SB ostium with TIMI ﬂow grade <3 in 6
(6.3%) patients. The baseline clinical characteristics are
shown in Table 1. The majority of patients were male (n ¼
77, 81.1%).
Angiographic and procedural details. Angiographic and
procedural characteristics are shown in Table 2. Bifurcation
lesions were located as follows: left anterior descending/
diagonal artery 51 (53.8%); left circumﬂex/obtuse marginal
artery 22 (23.2%); distal left main coronary artery 18 (18.9%);
and right coronary/posterior descending artery 4 (4.2%).
According to the Medina classiﬁcation, true bifurcation (type
1.1.1, type 1.0.1, and type 0.1.1) was observed in 75 (78.9%)
patients. First-generation DES were used in 53 (55.8%)
patients, whereas the remaining 42 patients received second-
generation DES. FKBI was performed in 89 (93.6%)
patients. In the remaining 6 patients, FKBI was not per-
formed because the operator did not feel the necessity due to
excellent angiographic result following stenting. Intravascular
ultrasound was performed in 41 (43.2%) patients. Procedural
Table 2. Angiographic and Procedural Characteristics (N ¼ 95)
SYNTAX score 14.7  6.5
Triple-vessel disease 43 (45.3)
Double-vessel 27 (28.4)
Single-vessel 25 (26.3)
Site of bifurcation
LAD/DA 51 (53.7)
LCX/obtuse marginal artery 22 (23.2)
Distal left main coronary artery 18 (18.9)
RCA/PDA 4 (4.2)
Medina classiﬁcation
1.1.1 33 (34.7)
0.1.1 28 (29.5)
1.0.1 14 (14.7)
1.1.0 8 (8.4)
0.1.0 7 (7.4)
1.0.0 5 (5.3)
Reason for TAP technique
Type B or higher grade of dissection in side branch 31 (32.6)
Residual stenosis 50% with TIMI ﬂow grade 3 in side branch 58 (61.1)
Residual stenosis 50% with TIMI ﬂow grade <3 in side branch 6 (6.3)
Sheath size
6-F 78 (82.1)
7-F 12 (12.6)
8-F 5 (5.3)
Intra-aortic balloon pumping 4 (4.2)
Intravascular ultrasound 41 (43.2)
Rotational atherectomy 4 (4.2)
FKBI 89 (93.6)
Main branch
Number of stents 1.22  0.44
Total stent length, mm 26.8  13.7
Maximum dilation pressure, atm 18.2  5.7
Side branch
Number of stents 1.02  0.14
Total stent length, mm 16.5  7.0
Maximum dilation pressure, atm 15.6  5.7
Type of DES
Sirolimus-eluting stent 41 (43.2)
Everolimus-eluting stent 20 (21.1)
Zotarolimus-eluting stent 14 (14.7)
Paclitaxel-eluting stent 12 (12.6)
Biolimus-eluting stent 8 (8.4)
Values are mean  SD or n (%).
DA ¼ diagonal artery; DES ¼ drug-eluting stent(s); FKBI ¼ ﬁnal kissing balloon inﬂation;
LAD¼ left anterior descending artery; LCX¼ left circumﬂex artery; PDA¼ posterior descending
artery; RCA ¼ right coronary artery; SYNTAX ¼ Synergy Between Percutaneous Coronary
Intervention With Taxus and Cardiac Surgery; TAP ¼ T-stenting and small protrusion; TIMI ¼
Thrombolysis In Myocardial Infarction.
Table 1. Baseline Clinical Characteristics (N ¼ 95)
Age, yrs 64.8  9.5
Male 77 (81.1)
Diabetes mellitus 25 (26.3)
Insulin 10 (10.5)
Dyslipidemia 63 (66.3)
Hypertension 61 (64.2)
Current smokers 10 (10.5)
LVEF, % 55.2  8.6
Previous MI 31 (32.6)
Previous PCI 48 (50.5)
Previous CABG 4 (4.2)
Family history of CAD 40 (42.1)
EuroSCORE 2.59  2.40
Angina type
Unstable angina 8 (8.4)
Stable angina 68 (71.6)
Silent ischemia 19 (20.0)
Values are mean  SD or n (%).
CABG ¼ coronary artery bypass graft; CAD ¼ coronary artery disease; EuroSCORE ¼
European System for Cardiac Operative Risk Evaluation; LVEF ¼ left ventricular ejection
fraction; MI ¼ myocardial infarction; PCI ¼ percutaneous coronary intervention.
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557success was achieved in all patients with no procedure-related
deaths or complications. However, there was 1 case (1.1%) of
periprocedural MI recorded. Quantitative coronary angiog-
raphy measurements at baseline and at the end of the
procedure are reported in Table 3. The frequency domain
optical coherence tomography (C7 XR, OCT Imaging
System, St. Jude Medical, St. Paul, Minnesota) and intra-
vascular ultrasound images of a patient treated with TAP
stenting are shown in Figures 2 and 3, demonstrating
complete ostial coverage with minimal overlap.
Clinical follow-up. The median follow-up period was
36.2 months (IQR: 20.8 to 52.1) and 50 (52%) patients
completed 36 months of follow-up. During the follow-up
period, 12 (12.6%) MACE occurred: 3 (3.2%) cardiac
deaths (6 all-cause deaths); 9 (9.5%) TVR; and 5 (5.3%)
TLR. Kaplan-Meier curves for MACE and TVR at 3-year
follow-up are shown in Figures 4 and 5. The outcome rates
at 3-year follow-up of MACE, cardiac death/follow-up MI,
TVR, and TLR were 12.9%, 3.1%, 9.7%, and 5.1%,
respectively. During the follow-up, 6 (6.3%) patients died, 3
were adjudicated as noncardiac (1 due to malignancy, 1 due
to renal failure, and 1 due to aspiration pneumonia). The
details of the cardiac deaths are shown in Table 4. Of the
3 cardiac deaths, 1 patient died suddenly at home about
21 months after the procedure was performed with siroli-
mus-eluting stents. The other 2 patients died suddenly at
31 and 36 months after implantation of paclitaxel-eluting
stents. Consequently, possible ST was adjudicated in these
3 patients. There were no cases of deﬁnite or probable ST.
Nine (9.5%) patients required TVR in the form of repeat
PCI. Five (5.3%) patients required TLR: 3 had focalrestenosis involving the SB ostium (bifurcation type 0.0.1);
1 had focal restenosis in the body of the MB stent (bifur-
cation type 0.1.0); and 1 had focal restenosis on the proximal
edge of the MB stent. All of the 5 patients who required
TLR had undergone FKBI.
Table 3. Quantitative Coronary Angiographic Measurements (N ¼ 95)
Main Branch Side Branch
Baseline
RVD, mm 3.12  0.54 2.50  0.43
MLD, mm 1.04  0.60 1.15  0.59
DS, % 66.4  17.3 55.2  20.6
Lesion length, mm 14.7  8.7 11.6  6.3
Final
RVD, mm 3.45  0.68 2.70  0.43
MLD, mm 3.14  0.65 2.38  0.46
DS, % 9.3  6.5 11.7  8.3
Acute gain, mm 2.09  0.83 1.24  0.70
Values are mean  SD.
DS ¼ diameter stenosis; MLD ¼ minimal lumen diameter; RVD ¼ reference vessel diameter.
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558Discussion
The main ﬁndings from our study of the long-term
outcomes of the TAP technique are:Figure 2. Coronary Angiography and FD-OCT Images
(A) Coronary angiography showing bifurcation lesion of the left anterior descending
dissection in the DA ostium after stent implantation in the LAD and kissing balloon in
[OCT] image). (C) Frequency domain optical coherence tomography (FD-OCT) showi1. The outcome rate of cardiac death was 3.1% at 3-year
follow-up.
2. The outcome rates of TVR and TLR were 9.7% and
5.1% at 3-year follow-up, respectively.
3. There were no cases of follow-up MI or ST (deﬁnite
and probable).
Although there are various techniques that can be used
for converting provisional stenting to 2-stent strategy
when required, most techniques (reversed culotte or
crush) are laborious and may not achieve complete
success due to technical difﬁculties. Although procedural
success has been reported to be over 95% in 2-stenting
strategies, FKBI was not performed in more than 20% of
cases (12). FKBI is considered mandatory for 2-stenting
strategies (especially crush and culotte) to reduce the
rates of restenosis and clinical events (3). The TAP
technique has some procedural advantages, such as it
does not require recrossing of the SB struts to perform
FKBI. In our cohort, the procedure was completedartery (LAD) and diagonal artery (DA). (B) Coronary angiography showing
ﬂation (panel C in Fig. 2B indicates the site of the optical coherence tomography
ng the coronary dissection (arrows) at the DA ostium.
Figure 3. Coronary Angiography, FD-OCT, and IVUS Images
(A) Coronary angiography following TAP stenting showing angiographically successful result. (B, E) FD-OCT showing good stent apposition in the LAD.
(C) FD-OCT showing complete stent coverage at the superior aspect of the DA ostium (proximal part of the bifurcation) with 2 layers of stent struts (arrows).
(D, D0) FD-OCT and intravascular ultrasound (IVUS) at the bifurcation showing the DA stent struts (arrows) with creation of a neo-carina following ﬁnal kissing balloon
inﬂation. (F) FD-OCT pulled back from DA also showing complete stent coverage (arrows) at the DA-ostium. BES ¼ biolimus-eluting stent(s); other abbreviations as in
Figures 1 and 2.
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559successfully in all patients. In addition, as the name
suggests, there is minimal protrusion of the SB stent into
the MB, leading to minimal stent overlap and, more
importantly, ensuring ostial coverage. These advantages
may theoretically reduce the rates of restenosis and ST.
In our study, there were no cases of deﬁnite or probable
ST in the relatively long-term follow-up. Furthermore,
the cardiac death rate was low, and there were no cases of
MI during the follow-up. In addition, the outcome rates
of TVR and TLR were 9.7% and 5.1% at 3-year follow-up, which are acceptable considering that the majority
were true bifurcation. Although our study did not
compare the TAP technique with other 2-stent strate-
gies, referring to previous studies reporting culotte and
crush techniques, the rates of TVR have ranged between
3% and 10% within the ﬁrst year of follow-up (3,4,6,13).
The 5-year outcome from the Nordic Bifurcation Study
recorded 3% cardiac death, 6.3% MI, 1.5% deﬁnite ST,
and 18.3% TVR in the 2-stent group, which suggests
that our results are acceptable (14). In addition, these
Figure 4. Kaplan-Meier Time-to-Event Curve for Major Adverse
Cardiac Events
Figure 5. Kaplan-Meier Time-to-Event Curve for Target
Vessel Revascularization
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560studies reported cases of deﬁnite or probable ST, which
was not encountered in our cohort. However, the possi-
bility of a chance ﬁnding could not be excluded due to
a relatively small number of patients in our study and the
rarity of this event. The majority (55.8%) of stents used
in our study were ﬁrst-generation; however, with the use
of newer generation stents, these results may further
improve.
In this study, we used the TAP technique in patients
requiring bailout SB stenting during a provisional stenting
strategy. However, there are no data comparing TAP to
other bailout strategies, and this should be the aim of future
studies. Furthermore, we should point out that this tech-
nique can also be used in conjunction with dedicated
bifurcation stents, which facilitate a provisional approach,
when stenting of the SB is required (15). Indeed, our data
suggest that TAP technique can certainly be considered for
bailout stenting during provisional stenting strategy.
Study limitations. This was a retrospective observational
study with a small number of patients.
 First, we did not compare the TAP technique with
other 2-stent strategies to claim technical and clinical
advantage.Table 4. Characteristics of the Patients With Cardiac Death
Sex, Age
Time-to-Cardiac-Death
(months) LVEF (%) EuroSCORE Cause of Death
Male, 72 yrs 21 30 9 Sudden death
Male, 55 yrs 36 55 1 Sudden death
Male, 76 yrs 31 47 5 Sudden death
DAT ¼ dual antiplatelet therapy; PES ¼ paclitaxel-eluting stent(s); SES ¼ sirolimus-eluting stent(s);
Tables 1 and 2. Although the TAP technique ensures complete ostial
coverage with minimal overlap, we were not able to
conﬁrm this by intravascular ultrasound or frequency
domain optical coherence tomography imaging in all
patients.
 The complete 3-year follow-up was not achieved in all
the patients.
 The majority of clinical presentation in our study was
stable angina. Therefore, this study cannot comment
on the feasibility and long-term success of TAP
stenting in all situations (such as acute coronary
syndromes).
 Finally, we cannot exclude the possibility that the
“oculostenotic reﬂex” could have played an important
role to trigger SB stenting as the criteria were not
based on the reduction of functional ﬂow reserve in
the SB.Conclusions
These results demonstrate that the TAP technique is
associated with acceptable clinical outcomes with no
episodes of deﬁnite and probable ST. Further studiesST Bifurcation Type of DES FKBI DAT
Possible, VLST LAD/DA SES Yes Continuous
Possible, VLST LCX/marginal artery PES Yes Unknown
Possible, VLST RCA/PDA PES No Continuous
ST ¼ stent thrombosis; VLST ¼ very late stent thrombosis; other abbreviations as in
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561should compare TAP technique with other 2-stent
strategies.
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